Journal of Clinical Case Reports is pleased to announce Special issue on “Reporting novel cases on Covid-19”
Coronavirus disease 2019 (COVID-19) is spreading worldwide. China's experience, for controlling of the current epidemic and treating patients, is of significant valuable for other countries to fight with COVID-19. In particular, traditional medicine therapies, such as prescription decoction, Chinese patent medicine, acupoint stimulation and Taiji, alone or adding to conventional drug therapies have been widely used and played a positive role in the mild, moderate and severe cases. In order to evaluate the efficacy and safety of traditional medicine therapies, there are hundreds of clinical study protocols registered in different registries. After the trials are completed, more evidence will be achieved, which will benefit the generalization and rational application of traditional medicine therapies. With the purpose of sharing knowledge and experience of traditional medicines for the treatment of COVID-19, the special issue of Integrative Medicine Research will provide evidence for the prevention and treatment of COVID-19.
With the same purpose our Journal “Journal of Clinical Case Reports” is announcing Special issue Call for paper on “Reporting novel cases on Covid-19”. We welcome both solicited and unsolicited submissions that will contribute to this special issue.
Submission Process (take from special issue guidelines)
For further information on special issue guidelines and submission process, please contact [email protected]
Please visit Instruction for authors page to know more about article formatting and guidelines: https://www.hilarispublisher.com/clinical-case-reports/instructionsforauthors.html